A carregar...
Triple action Pt(iv) derivatives of cisplatin: a new class of potent anticancer agents that overcome resistance
A series of triple action Pt(iv) prodrugs was designed to test the hypothesis that multi-action compounds, where each bioactive moiety intervenes in several cellular processes, might be more effective than a single agent at killing cancer cells. In particular, “triple action” Pt(iv) derivatives of c...
Na minha lista:
| Publicado no: | Chem Sci |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Royal Society of Chemistry
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5944384/ https://ncbi.nlm.nih.gov/pubmed/29780561 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1039/c8sc00428e |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|